Skip to main content
. 2012 Jun;32(6):248–253. doi: 10.1089/jir.2011.0109

FIG. 3.

FIG. 3.

The changes in the levels of serum IL-33 and sST2 in CHC patients with IFN treatment. Data are expressed as the mean values of individual participants from two separate experiments. The horizontal lines show the median. (A) The changes in the levels of serum IL-33. (B) The changes in the levels of serum sST2.